<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref71">
 <mixed-citation publication-type="other">
  <person-group person-group-type="author">
   <name>
    <surname>Tallei</surname>
    <given-names>T. E.</given-names>
   </name>
   <name>
    <surname>Tumilaar</surname>
    <given-names>S. G.</given-names>
   </name>
   <name>
    <surname>Niode</surname>
    <given-names>N. J.</given-names>
   </name>
   <name>
    <surname>Fatimawali</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Kepel</surname>
    <given-names>B. J.</given-names>
   </name>
   <name>
    <surname>Idroes</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors a molecular docking study. Preprints [Preprint], 2020040102. 
  <pub-id pub-id-type="doi">10.20944/preprints202004.0102.v1</pub-id>
 </mixed-citation>
</ref>
